Hospital Universitario de Getafe -ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2024

  1. Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human

    Vascular Pharmacology, Vol. 155

2023

  1. The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit

    Biomedicine and Pharmacotherapy, Vol. 164

2021

  1. Article serum micrornas as biomarkers of sepsis and resuscitation

    Applied Sciences (Switzerland), Vol. 11, Núm. 23

  2. Case Studies in Physiology: Physiological and clinical effects of temporary diaphragm pacing in two patients with ventilator-induced diaphragm dysfunction

    Journal of Applied Physiology, Vol. 130, Núm. 6, pp. 1736-1742

  3. Extracellular Vesicles and Alveolar Epithelial-Capillary Barrier Disruption in Acute Respiratory Distress Syndrome: Pathophysiological Role and Therapeutic Potential

    Frontiers in Physiology, Vol. 12

  4. Interleukin-6 and intrapulmonary shunt

    European Respiratory Journal

  5. Oxygen-sensitivity and pulmonary selectivity of vasodilators as potential drugs for pulmonary hypertension

    Antioxidants, Vol. 10, Núm. 2, pp. 1-14

2013

  1. Antioxidant effect of human adult adipose-derived stromal stem cells in alveolar epithelial cells undergoing stretch

    Respiratory Physiology and Neurobiology, Vol. 188, Núm. 1, pp. 1-8

  2. Pulmonary vascular dysfunction induced by high tidal volume mechanical ventilation

    Critical Care Medicine, Vol. 41, Núm. 8

2012

  1. Different patterns of pulmonary vascular disease induced by type 1 diabetes and moderate hypoxia in rats

    Experimental Physiology, Vol. 97, Núm. 5, pp. 676-686

2011

  1. Type 1 diabetes-induced hyper-responsiveness to 5-hydroxytryptamine in rat pulmonary arteries via oxidative stress and induction of cyclooxygenase-2

    Journal of Pharmacology and Experimental Therapeutics, Vol. 338, Núm. 1, pp. 400-407

2010

  1. Levosimendan increases portal blood flow and attenuates intestinal intramucosal acidosis in experimental septic shock

    Shock, Vol. 34, Núm. 3, pp. 275-280